Research Article

GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial

Table 3

Univariate and multivariate analyses of risk factors for the overall survival.

Univariate analysisMultivariate analysis
Hazard ratio95% CI

Age (year)
 <65/≥650.448
Gender
 Male/female0.679
Tumor location
 Upper/middle/lower0.156
cT
 T1/T2/T30.0282.3661.233–4.5690.01
cN
 N0/N+0.014
Pathological grade
 G1/G2/G30.044
GASC1 expression
 High/low0.0391.891.011–4.2160.048

Log-rank test. Adjusted 95% confidence interval. Cox proportional hazard model.